Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-03-05 Sale |
2024-03-07 4:59 pm |
Y-mAbs Therapeutics Inc. | YMAB | Smith Susan Laura SVP & CHIEF COMMERCIAL OFFICER |
1,682 | $16.55 | $27,837 | 33,918 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-01-18 Option Award |
2024-01-22 6:00 pm |
N/A 2034-01-18 |
Y-mAbs Therapeutics Inc. | YMAB | Smith Susan Laura SVP & CHIEF COMMERCIAL OFFICER |
53,500 | $0 | 71,300 (Direct) |
View |
| 2023-01-26 Option Award |
2023-01-30 4:32 pm |
N/A 2033-01-26 |
Y-mAbs Therapeutics Inc. | YMAB | Smith Susan Laura SVP & CHIEF COMMERCIAL OFFICER |
32,000 | $0 | 32,000 (Direct) |
View |
| 2023-01-17 Option Award |
2023-01-19 4:40 pm |
N/A 2033-01-17 |
Y-mAbs Therapeutics Inc. | YMAB | Smith Susan Laura SVP & CHIEF COMMERCIAL OFFICER |
53,500 | $0 | 53,500 (Direct) |
View |
| 2022-04-26 Option Award |
2022-04-28 6:20 pm |
N/A 2032-04-26 |
Y-mAbs Therapeutics Inc. | YMAB | Smith Susan Laura SVP & CCO |
20,000 | $0 | 20,000 (Direct) |
View |
| 2021-12-14 Option Award |
2021-12-23 4:55 pm |
N/A 2031-12-14 |
Y-mAbs Therapeutics Inc. | YMAB | Smith Susan Laura SVP & CCO |
64,000 | $0 | 64,000 (Direct) |
View |